Answers are grounded in this paper and cite their sources.
Background: Synthetic corticosteroids are widely prescribed for their anti-inflammatory and immunosuppressive properties. However, they can induce significant psychiatric adverse effects such as mood disorders, psychosis, and cognitive changes. Methods: We conducted a prospective observational study over 12 months at a tertiary-care hospital. Adult patients ( n = 200) receiving moderate-to-high doses of synthetic corticosteroids for various medical conditions were enrolled. Psychiatric assessments were performed at baseline, 4 weeks, and 12 weeks using standardized validated tools (e.g., Hamilton Depression Rating Scale, Young Mania Rating Scale, and Brief Psychiatric Rating Scale). Results: Of the 200 participants, 30% ( n = 60) developed new-onset or worsened psychiatric symptoms. The most common presentations were mood disturbances (17%), anxiety (8%), and psychotic features (5%). Risk factors included higher corticosteroid doses (>40 mg/day of prednisone or equivalent), longer treatment duration (>8 weeks), and a history of mood or anxiety disorders. Conclusion: Synthetic corticosteroids are associated with an increased risk of psychiatric adverse effects. Early identification, regular monitoring, and prompt management of psychiatric symptoms are crucial. Awareness among clinicians and multidisciplinary collaboration can help mitigate these risks and improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Mukherjee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: